{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:57:40Z","timestamp":1792749460202,"version":"4.5.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hereditary Spherocytosis (HS) is a rare, congenital red blood cell disorder presenting with variable clinical manifestations ranging from mild hemolytic anemia to severe anemia with hypersplenism and hepatobiliary complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The objectives of the study were to evaluate the diagnostic pathway of HS, the presence and management of hepatobiliary complications in pediatric patients with HS followed in a tertiary care center. The demographic, clinical, hematological information were retrieved from medical records of patients having at least 1 hematology visit between 2010 and 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Forty-two patients were enrolled, 23 M. Mean age at onset of symptoms was 2.8 years, at diagnosis was 3.5 years. Anemia was the first manifestation in 73%; suspect of HS arose for all patients in first or second level outpatient clinics. Only 64% of patients performed two confirmation tests in the reference center. 28\/42 had familiarity for HS; of the 13\/42 who did not, only 47% performed further analysis. Sixteen patients developed gallbladder stones (40%), visible at the first ultrasound (5.6 years). Hemolytic crises and parvovirus infections were more frequent in patients with stones (53.6% vs. 26.1% and 63.6% vs. 28.6%, respectively). 10\/16 (62.5%) underwent elective cholecystectomy: 8 had concomitant splenectomy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>our study highlights the need to optimize the diagnostic pathway in networks of care involving general and specialized centers in order to reduce time to diagnosis and ensure that all patients receive confirmatory tests. A high frequency of hepatobiliary complications since young age was observed suggesting that screening with ultrasound should begin earlier<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2023.1269645","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T10:33:56Z","timestamp":1696847636000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Hematological characteristics and hepatobiliary complications of hereditary spherocytosis in a tertiary care pediatric center: optimizing diagnosis and care through local and international networks"],"prefix":"10.3389","volume":"11","author":[{"given":"Maria Paola","family":"Boaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Reggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"D\u2019Agnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Munaretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pozzebon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Trapanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Martella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Colombatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0140-6736(08)61588-3","article-title":"Hereditary spherocytosis","volume":"372","author":"Perrotta","year":"2008","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.blre.2006.03.005","article-title":"The molecular basis of hereditary red cell membrane disorders","volume":"21","author":"Delaunay","year":"2007","journal-title":"Blood Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.1002\/ajh.24713","article-title":"Recombinant erythropoietin vs. Blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A. I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica)","volume":"92","author":"Farruggia","year":"2017","journal-title":"Am J Hematol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.siny.2015.12.001","article-title":"Anemia and transfusion in the neonate","volume":"21","author":"Colombatti","year":"2016","journal-title":"Semin Fetal Neonatal Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2141.2011.08921.x","article-title":"Guidelines for the diagnosis and management of hereditary spherocytosis\u20132011 update","volume":"156","author":"Bolton-Maggs","year":"2012","journal-title":"Br J Haematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1365-2141.2004.05052.x","article-title":"Guidelines for the diagnosis and management of hereditary spherocytosis","volume":"126","author":"Bolton-Maggs","year":"2004","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3324\/haematol.2011.052845","article-title":"Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics","volume":"97","author":"Bianchi","year":"2012","journal-title":"Haematologica"},{"key":"B8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1515\/cclm-2016-0290","article-title":"Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience","volume":"55","author":"Lazarova","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/jha2.277","article-title":"Facilitating EMA binding test performance using fluorescent beads combined with next-generation sequencing","volume":"2","author":"Glenth\u00f8j","year":"2021","journal-title":"EJHaem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1097\/HS9.0000000000000739","article-title":"The use of next-generation sequencing in the diagnosis of rare inherited anaemias: a joint BSH\/EHA good practice paper","volume":"6","author":"Roy","year":"2022","journal-title":"Hemasphere"},{"key":"B11","first-page":"43","article-title":"The Italian pediatric survey on hereditary spherocytosis","volume":"2","author":"Pinto","year":"1995","journal-title":"Int J Paediatr Hematol Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s0022-3476(05)81081-9","article-title":"Variable clinical severity of hereditary spherocytosis: relation to erythrocytic spectrin concentration, osmotic fragility, and autohemolysis","volume":"117","author":"Eber","year":"1990","journal-title":"J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3324\/haematol.2016.161166","article-title":"Recommendations regarding splenectomy in hereditary hemolytic anemias","volume":"102","author":"Iolascon","year":"2017","journal-title":"Haematologica"},{"key":"B14","year":""},{"key":"B15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","article-title":"Whole-genome sequencing of patients with rare diseases in a national health system","volume":"583","author":"Turro","year":"2020","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"s606","DOI":"10.2450\/2014.0064-14s","article-title":"The Italian national rare diseases registry","volume":"12","author":"Taruscio","year":"2014","journal-title":"Blood Transfus"},{"key":"B17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1750-1172-9-37","article-title":"A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto region\u2019s rare diseases registry","volume":"9","author":"Mazzucato","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/00043426-200312000-00009","article-title":"High incidence of early cholelithiasis detected by ultrasonography in children and young adults with hereditary spherocytosis","volume":"25","author":"Tamary","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5581\/1516-8484.20120006","article-title":"Clinical course of 63 children with hereditary spherocytosis: a retrospective study","volume":"34","author":"Oliveira","year":"2012","journal-title":"Rev Bras Hematol Hemoter"},{"key":"B20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bjh.16244","article-title":"Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: first south Asian study","volume":"188","author":"Aggarwal","year":"2020","journal-title":"Br J Haematol"},{"key":"B21","first-page":"473","article-title":"Surgical management of hereditary spherocytosis current strategies","volume":"89","author":"Vecchio","year":"2018","journal-title":"Ann Ital Chir"},{"key":"B22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jpedsurg.2013.05.012","article-title":"Synchronous Splenectomy during cholecystectomy for hereditary spherocytosis: is it really necessary?","volume":"49","author":"Ruparel","year":"2014","journal-title":"J Pediatr Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jpedsurg.2022.11.012","article-title":"Treatment of asymptomatic gallstones in children with hereditary spherocytosis requiring splenectomy","volume":"58","author":"Liu","year":"2023","journal-title":"J Pediatr Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3324\/haematol.12546","article-title":"Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect","volume":"93","author":"Mariani","year":"2008","journal-title":"Haematologica"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1097\/HS9.0000000000000591","article-title":"Metabolic fingerprint in hereditary spherocytosis correlates with red blood cell characteristics and clinical severity","volume":"5","author":"van Dooijeweert","year":"2021","journal-title":"Hemasphere"},{"key":"B26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3324\/haematol.2018.188151","article-title":"Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis","volume":"105","author":"Huisjes","year":"2020","journal-title":"Haematologica"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.97\/01.HS9.0000928272.17774.91","article-title":"Rare anemia disorder European. Epidemiological platform (RADeep)","volume":"7","author":"Colombatti","year":"2023","journal-title":"HemaSphere"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1269645\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T10:34:03Z","timestamp":1696847643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1269645\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":27,"alternative-id":["10.3389\/fped.2023.1269645"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1269645","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"article-number":"1269645"}}